Enhabit Past Earnings Performance
Past criteria checks 0/6
Enhabit's earnings have been declining at an average annual rate of -54.2%, while the Healthcare industry saw earnings growing at 10.6% annually. Revenues have been declining at an average rate of 1.4% per year.
Key information
-54.2%
Earnings growth rate
-77.5%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | -1.4% |
| Return on equity | -19.1% |
| Net Margin | -11.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Enhabit makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,037 | -117 | 436 | 0 |
| 30 Jun 24 | 1,042 | -9 | 441 | 0 |
| 31 Mar 24 | 1,044 | -83 | 439 | 0 |
| 31 Dec 23 | 1,046 | -80 | 442 | 0 |
| 30 Sep 23 | 1,049 | -169 | 432 | 0 |
| 30 Jun 23 | 1,056 | -158 | 430 | 0 |
| 31 Mar 23 | 1,062 | -64 | 425 | 0 |
| 31 Dec 22 | 1,071 | -40 | 415 | 0 |
| 30 Sep 22 | 1,084 | 84 | 414 | 0 |
| 30 Jun 22 | 1,092 | 97 | 410 | 0 |
| 31 Mar 22 | 1,110 | 109 | 414 | 0 |
| 31 Dec 21 | 1,107 | 111 | 413 | 0 |
| 31 Dec 20 | 1,078 | 75 | 398 | 0 |
| 31 Dec 19 | 1,092 | 24 | 466 | 0 |
Quality Earnings: X34 is currently unprofitable.
Growing Profit Margin: X34 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: X34 is unprofitable, and losses have increased over the past 5 years at a rate of 54.2% per year.
Accelerating Growth: Unable to compare X34's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: X34 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (40.5%).
Return on Equity
High ROE: X34 has a negative Return on Equity (-19.08%), as it is currently unprofitable.